1. Home
  2. GNPX vs BBGI Comparison

GNPX vs BBGI Comparison

Compare GNPX & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • BBGI
  • Stock Information
  • Founded
  • GNPX 2009
  • BBGI 1961
  • Country
  • GNPX United States
  • BBGI United States
  • Employees
  • GNPX N/A
  • BBGI N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • BBGI Broadcasting
  • Sector
  • GNPX Health Care
  • BBGI Consumer Discretionary
  • Exchange
  • GNPX Nasdaq
  • BBGI Nasdaq
  • Market Cap
  • GNPX 6.6M
  • BBGI 8.1M
  • IPO Year
  • GNPX 2018
  • BBGI 2000
  • Fundamental
  • Price
  • GNPX $0.23
  • BBGI $3.90
  • Analyst Decision
  • GNPX
  • BBGI
  • Analyst Count
  • GNPX 0
  • BBGI 0
  • Target Price
  • GNPX N/A
  • BBGI N/A
  • AVG Volume (30 Days)
  • GNPX 3.6M
  • BBGI 76.3K
  • Earning Date
  • GNPX 08-08-2025
  • BBGI 08-11-2025
  • Dividend Yield
  • GNPX N/A
  • BBGI N/A
  • EPS Growth
  • GNPX N/A
  • BBGI N/A
  • EPS
  • GNPX N/A
  • BBGI N/A
  • Revenue
  • GNPX N/A
  • BBGI $234,823,730.00
  • Revenue This Year
  • GNPX N/A
  • BBGI $5.02
  • Revenue Next Year
  • GNPX N/A
  • BBGI N/A
  • P/E Ratio
  • GNPX N/A
  • BBGI N/A
  • Revenue Growth
  • GNPX N/A
  • BBGI N/A
  • 52 Week Low
  • GNPX $0.20
  • BBGI $3.67
  • 52 Week High
  • GNPX $3.97
  • BBGI $14.95
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 40.22
  • BBGI 33.07
  • Support Level
  • GNPX $0.22
  • BBGI $3.67
  • Resistance Level
  • GNPX $0.32
  • BBGI $5.26
  • Average True Range (ATR)
  • GNPX 0.03
  • BBGI 0.29
  • MACD
  • GNPX -0.01
  • BBGI -0.04
  • Stochastic Oscillator
  • GNPX 22.07
  • BBGI 14.47

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

Share on Social Networks: